Skip to content

Hearing Health for Korean American Older Adults With Mild Cognitive Impairment

K-HEARS MCI: Hearing Health Care for Korean American Older Adults With Mild Cognitive Impairment - Pilot

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06068933
Acronym
K-HEARS MCI
Enrollment
1
Registered
2023-10-05
Start date
2023-12-12
Completion date
2024-11-27
Last updated
2025-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related Hearing Impairment, Mild Cognitive Impairment, Personal Communication

Brief summary

The objective of this study is to develop and assess the feasibility, acceptability, and preliminary efficacy of a community-delivered, affordable, and accessible hearing care intervention tailored to the needs of community-dwelling Korean American (KA) older adults with mild cognitive impairment (MCI) and their care partners that integrates a low-cost over-the-counter amplification device and hearing rehabilitation through a randomized controlled pilot study. Each dyad will consist of the study participant and their care partner.

Detailed description

The study consists of three phases: 1) Phase 1: development of the intervention through exploratory focus groups and/or semi-structured interviews and prototyping via open-labeled trial 2) Phase 2A: randomized, controlled pilot study with study participants randomized to an immediate treatment group, versus a 6-month delayed treatment group of an intervention specific for individuals with MCI, 3) Phase 2B: a non-randomized pragmatic-focused trial of community-dwelling older KAs with hearing loss but without MCI, and 4) Phase 3: qualitative evaluation of the experience and supplemental feedback through exploratory focus groups and/or semi-structured interviews.

Interventions

Tailored aural rehabilitation for participant and care partner

Tailored fitting and programming of a personal sound amplifier. This will be accompanied by a component of aural rehabilitation.

Sponsors

National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Participants in Phase 2-A MCI Focused Trial will be randomized into a two arms: immediate intervention and delayed intervention. Participants in Phase 2-B KA Older Adult Focused Trial will not be randomized.

Eligibility

Sex/Gender
ALL
Age
60 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

PARTICIPANT INCLUSION CRITERIA FOR PHASE 2A: MCI-Pilot Trial * Age ≥ 60 years * Self-identified as first-generation Korean American * Self-reported ability to read and speak Korean * Hearing loss identified by screening audiometry pure-tone-average (PTA) 1, 2, 4 kilohertz \> 25 decibel hearing loss in better hearing ear * Mild cognitive impairment (CDR=0.5 and/or Korean Montreal Cognitive Assessment (MoCA-K) \<23) * Report not currently using a hearing aid * Has a care partner able to participate in the study * Stable medication regimen. Stable (for 2 weeks or longer) dosing of medication (e.g. antidepressants, antipsychotics) for neuropsychiatric symptoms PARTICIPANT INCLUSION CRITERIA FOR PHASE 2B: KA Older Adult-focused Trial: * Age ≥ 60 years * Self-identified as first-generation Korean American * Self-reported ability to read and speak Korean * Hearing loss identified by screening audiometry pure-tone-average (PTA) 1, 2, 4 kilohertz \>= 35 decibel Hearing Loss in better hearing ear * Report not currently using a hearing aid * Has a care partner able to participate in the study CARE PARTNER INCLUSION CRITERIA (same for both Phase 2A and 2B) * Age 18 years or older * Able to read and speak Korean * Lives in the same household with the participant or has at least daily interactions * Aural-oral verbal communication as primary communication modality * Able to accompany participant to all study visits

Exclusion criteria

(same for both Phase 2A and 2B) Participant

Design outcomes

Primary

MeasureTime frameDescription
Hearing Handicap Inventory for the Elderly (HHIE-S) scoreBaseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)Score range 0-40. 0-8 suggests no hearing handicap 10-24 suggests mild-moderate hearing handicap 26-40 suggests significant hearing handicap.

Secondary

MeasureTime frameDescription
Revised UCLA Loneliness ScaleBaseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)Score is the sum of 20-item self-reported measure. Scores range from 20 to 80. Score ranges: 20-34 - Low degree of loneliness 35-49 - Moderate degree of loneliness 50-64 - Moderately high degree of loneliness 65-80 - High degree of loneliness.
Short Form-12 (SF-12) Mental Component ScoreBaseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)The 12-Item Short Form Survey (SF-12) measures the construct of self-reported health-related quality of life. Score ranges from 0-100 with higher scores indicating better mental health functioning.
Social Network size Measured by Lubben Social Network IndexBaseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)Measures social network size for both family and friends and also the frequency of interaction with them. Higher scores indicate higher level of social engagement. Score range (0-30).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026